MAGI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.955400E-01
Normal-vs-Stage2
2.729200E-01
Normal-vs-Stage3
3.035700E-02
Normal-vs-Stage4
5.314400E-01
Stage1-vs-Stage2
2.780000E-01
Stage1-vs-Stage3
6.810300E-02
Stage1-vs-Stage4
3.607200E-01
Stage2-vs-Stage3
1.330960E-01
Stage2-vs-Stage4
3.152300E-02
Stage3-vs-Stage4
1.584190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.571200E-01
Normal-vs-AfricanAmerican
8.172600E-01
Normal-vs-Asian
2.329800E-01
Caucasian-vs-AfricanAmerican
6.126200E-01
Caucasian-vs-Asian
8.536800E-01
AfricanAmerican-vs-Asian
4.921800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.847400E-01
Normal-vs-Female
2.708200E-01
Male-vs-Female
9.851200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.684200E-01
Normal-vs-Age(41-60Yrs)
4.207800E-01
Normal-vs-Age(61-80Yrs)
2.462800E-01
Normal-vs-Age(81-100Yrs)
5.992400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.903600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.826200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.294810E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.893800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.198000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.881600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.706200E-01
Normal-vs-Daily Drinker
8.445900E-02
Normal-vs-Weekly Drinker
2.948600E-01
Normal-vs-Occasional Drinker
5.181400E-01
Normal-vs-Social Drinker
3.136600E-01
Non Drinker-vs-Daily Drinker
2.245600E-01
Non Drinker-vs-Weekly Drinker
9.177200E-01
Non Drinker-vs-Occasional Drinker
5.268000E-01
Non Drinker-vs-Social Drinker
9.304400E-01
Daily Drinker-vs-Weekly Drinker
3.719000E-01
Daily Drinker-vs-Occasional Drinker
1.104400E-01
Daily Drinker-vs-Social Drinker
2.629200E-01
Weekly Drinker-vs-Occasional Drinker
5.552800E-01
Weekly Drinker-vs-Social Drinker
8.717800E-01
Occasional Drinker-vs-Social Drinker
6.495200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.024200E-02
Normal-vs-Grade 2
1.581550E-02
Normal-vs-Grade 3
2.178200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.513000E-01
Grade 1-vs-Grade 3
9.476600E-01
Grade 1-vs-Grade 4
8.024200E-02
Grade 2-vs-Grade 3
4.124800E-01
Grade 2-vs-Grade 4
1.581550E-02
Grade 3-vs-Grade 4
2.178200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.865970E-01
Normal-vs-NonDiabetic
1.885980E-01
Diabetic-vs-NonDiabetic
5.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.476200E-02
Normal-vs-NoPancreatitis
2.173000E-01
Pancreatitis-vs-NoPancreatitis
2.204400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.337800E-01
Normal-vs-N1
3.071600E-01
N0-vs-N1
4.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.831000E-01
Normal-vs-TP53-NonMutant
5.469600E-01
TP53-Mutant-vs-TP53-NonMutant
5.565600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
